PN

Pavani Nula

Active Director Additional Director DIN 09595054
DIN 09595054 First appointment Jun 2022 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Pavani Nula

Data last updated:

Pavani Nula is an Additional Director at Aurona Med Pharma Private Limited (since 2022). The company operates in Food And Beverages.

DIN 09595054
Primary Designation Additional Director
Industry Food And Beverages
First Appointment 16 Jun 2022
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aurona Med Pharma Private Limited U24304TG2019PTC135442
Additional Director16 Jun 20222019Active

Board colleagues of Pavani Nula

Directorship timeline

Open interactive timeline →
Aurona Med Pharma Private Limited
Premium access

Shareholding and investment profile for Pavani Nula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pavani Nula

Pavani Nula currently holds 1 directorship: Aurona Med Pharma Private Limited (Additional Director, since 16 Jun 2022).

Pavani Nula was first appointed on 16 Jun 2022 as Additional Director at Aurona Med Pharma Private Limited.

The current boards of Pavani Nula's companies include Konda Veeraswamy (Aurona Med Pharma Private Limited), Rani Deepa (Aurona Med Pharma Private Limited), Ravinder Yadav Mogli (Aurona Med Pharma Private Limited), Santhosha Maila (Aurona Med Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available